MBL CB EUR650m FXD due 18 February 2031
Summary by AI BETAClose X
Announcement
Publication of Final Terms
The following Final Terms are available for viewing:
Final Terms dated 16 February 2026 relating to EUR650,000,000 Fixed Rate Covered Bonds due 18 February 2031 issued by Macquarie Bank Limited (MBL) under the AUD10,000,000,000 MBL Covered Bond Programme (the Programme), as described in the base prospectus relating to the Programme dated 6 June 2025 as supplemented by the supplementary prospectuses dated 30 June 2025 and 7 November 2025 and as supplemented from time to time (the Base Prospectus)
To view the full document, please paste the following URL into the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/4336T_1-2026-2-18.pdf
A copy of the Final Terms has also been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
For further information, please contact:
Macquarie Bank Limited
Mr. Francisco Sarmiento
1 Elizabeth Street
Sydney NSW
Australia
Telephone : +61 2 8232 3333
Fax : +61 2 8232 4227
Email : Francisco.Sarmiento@macquarie.com
DISCLAIMER ‑ INTENDED ADDRESSEES
Please note that the information contained in the Final Terms and Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus and Final Terms is not addressed. Prior to relying on the information contained in the Base Prospectus and Final Terms you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.
This publication does not constitute an offering of debt instruments (the "Instruments"), and is not for distribution in or into the United States. The Instruments have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), or any relevant securities laws of any state of the United States and, subject to certain exceptions, the Instruments may not be offered, sold or delivered in the United States or to, or for the account or benefit of, U.S. persons, as such terms are defined in Regulation S under the Securities Act. Instruments in bearer form are subject to U.S. tax law requirements and may not be offered, sold or delivered within the United States or its possessions or to a U.S. person, except in certain transactions permitted by U.S. tax regulations. Terms used in the preceding sentence have the meanings given to them by the U.S. Internal Revenue Code and regulations thereunder. There will be no public offering of the Instruments in the United States.
Your right to access this service is conditional upon complying with the above requirement.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 7 hours ago Luceco
- 7 hours ago Helios Towers
- 8 hours ago Wise Class A
- 8 hours ago EDX Medical Group Plc
- 8 hours ago Naked Wines